… Maintenance therapy can delay progression and prolong survival in metastatic non-small-cell
lung cancer (… study investigating the impact of erlotinib maintenance therapy on HRQoL in …

… of erlotinib and pemetrexed as maintenance therapy … maintenance therapy group were
excluded in this meta-analysis. In another trial, erlotinib was used as a continuous maintenance …

… Maintenance therapy, commenced immediately after the … patients with non-small-cell lung
cancer (NSCLC). The global … -kinase inhibitor erlotinib as maintenance treatment in NSCLC …

Purpose This phase III study investigated whether continuation maintenance with
gemcitabine or switch maintenance with erlotinib improves clinical outcome compared with …

… The Sequential Tarceva in Unresectable NSCLC (SATURN) trial investigated maintenance
erlotinib compared with placebo in patients who did not experience PD after four cycles of …

… This article presents a summary of the ERG report for the STA of erlotinib as monotherapy
for the maintenance treatment of patients with non-small cell lung cancer (NSCLC) and stable …

… Erlotinib was approved for first-line maintenance in a stable disease population … erlotinib
with best supportive care. We aimed to estimate the incremental cost-effectiveness of erlotinib …

… of erlotinib plus DC/CIK in maintenance therapy of advanced non–small cell lung cancer.
After 4 … , the 54 patients with non–small cell lung cancer in phase IIIb or IV reached stable or …

… In the scenario where erlotinib maintenance therapy was given, the use of pemetrexed
and … would not be given erlotinib in 2nd line if they had received it as maintenance therapy. …

… The primary endpoint of SATURN is to determine whether administration of maintenance
erlotinib after standard platinum-based chemotherapy increases progression-free survival …